awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37913983-914138E7-E440-419F-B337-7ED51E8AE204
Q37913983-914138E7-E440-419F-B337-7ED51E8AE204
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37913983-914138E7-E440-419F-B337-7ED51E8AE204
The changing therapeutic landscape of castration-resistant prostate cancer.
P2860
Q37913983-914138E7-E440-419F-B337-7ED51E8AE204
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37913983-914138E7-E440-419F-B337-7ED51E8AE204
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
97aad9ab1858c83628f01685fc2e95ad63d01ca1
P2860
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.